跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DALINGO 330 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DALINGO 330 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Approved
STANDARD
DALINGO 330 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Laboratorios Gebro Pharma S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
43f81fa860fba279
Company
Laboratorios Gebro Pharma S.A.
Type
Standard
Approval Details
Approval Id
43f81fa860fba279
Drug Cima Aemps Name
DALINGO 330 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Register Number
89265
Holder Company Name
Laboratorios Gebro Pharma S.A.
Marketing Company Name
Laboratorios Gebro Pharma S.A.
Authorization Date
2024-02-13
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
330 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Gebro Pharma S.A.
Active Ingredients
PREGABALINA
330 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
43f81fa860fba279
Type
Standard
Back to CIMA-AEMPS Approvals
